<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03343028</url>
  </required_header>
  <id_info>
    <org_study_id>39006</org_study_id>
    <nct_id>NCT03343028</nct_id>
  </id_info>
  <brief_title>Biomarker Establishment for Superior Treatment of PTSD</brief_title>
  <official_title>Biomarker Establishment for Superior Treatment of PTSD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>New Mexico VA Healthcare System</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of Biomarker Establishment for Superior Treatment of PTSD is to accelerate
      research on the discovery of biological, neurological and neuroimaging markers for Post-
      Traumatic Stress Disorder (PTSD). The investigators hope to validate and extend the network
      efficiency and verbal memory biomarker for PTSD. The investigators hope to learn whether
      there are pretreatment biological factors that can predict response to therapy. They want to
      do this by understanding the brain network function, relating EEG to functional magnetic
      resonance imaging, and application of network analysis tool.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Actual">September 30, 2019</completion_date>
  <primary_completion_date type="Actual">September 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Understanding the brain network function-neuroimaging and behavioral with Clinician-Administered PTSD Scale for DSM-5</measure>
    <time_frame>Approximately 3 months</time_frame>
    <description>We will be using CAPS 5</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">292</enrollment>
  <condition>PTSD</condition>
  <arm_group>
    <arm_group_label>Psychotherapy</arm_group_label>
    <description>The investigators will assess and acquire data on these Veterans across the course of the project prior to and after receiving Prolonged Exposure (PE) or Cognitive Processing Theory (CPT) treatment at VA Palo Alto (VAPAHCS) and the Albuquerque VA. They will acquire fMRI, behavioral, EEG, TMS/EEG, and saliva at baseline on these Veterans and again 3 months after treatment to assess prediction and durability of the clinical and brain/behavioral metrics. All study assessments will take place at Stanford University/VAPAHCS. Subjects will be recruited through VAPAHCS and Albuquerque VA. Subjects will complete a clinical assessment including: neuroimaging, self-report questionnaires completed via computer or paper-and-pencil, cognitive testing, saliva, and TMS and EEG assessments.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>The investigators will assess and acquire data on these Veterans who do not have history of PTSD and have no history of any Axis I psychiatric disorder, are taking psychotropic medication, or use illicit drugs. They will acquire fMRI, behavioral, EEG, TMS/EEG, and saliva once. All study assessments will take place at Stanford University. Subjects will be recruited through public flying, online ads and VAPAHCS. Subjects will complete a clinical assessment including: neuroimaging, self-report questionnaires completed via computer or paper-and-pencil, cognitive testing, saliva, and TMS and EEG assessments.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Psychotherapy</intervention_name>
    <arm_group_label>Psychotherapy</arm_group_label>
    <other_name>Cognitive Processing Therapy</other_name>
    <other_name>Prolonged Exposure</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We will assess and acquire data on these Veterans across the course of the project prior to
        and after receiving Prolonged Exposure (PE) or Cognitive Processing Theory (CPT) treatment
        at VA Palo Alto (VAPAHCS) and the Albuquerque VA.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of PTSD by VA clinicians and acceptance into PE or CPT treatment as part of
             the PCT

          -  Veterans of any era

        Exclusion Criteria:

          -  MRI safety contraindications

          -  Active, uncontrolled medical illness

          -  Acute suicidality

          -  Current substance dependence

          -  Current use of thyroid medication or active hyper/hypothyroidism

          -  Neurological disorder affecting the CNS Seg stroke, epilepsy, tumorW or penetrating
             head injury

          -  Use of PRN within 48 hours of the MRI/EEG
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Schatzberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System (VAPAHCS)</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Mexico VA Health Care System</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://etkinlab.stanford.edu/</url>
    <description>About our lab</description>
  </link>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 4, 2016</study_first_submitted>
  <study_first_submitted_qc>November 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Alan Schatzberg</investigator_full_name>
    <investigator_title>Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences</investigator_title>
  </responsible_party>
  <keyword>veterans</keyword>
  <keyword>post traumatic stress disorder</keyword>
  <keyword>depression</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

